Paper35945641
Role of m6A writers, erasers and readers in cancer.
Fang Z and 6 others. Exp Hematol Oncol, 2022. Cited by 213 papers, by iCite.
Cite this record
ConductScience Library. Role of m6A writers, erasers and readers in cancer. Papers, record 35945641. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/35945641
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| Z171100001017077 | Beijing Municipal Science & Technology Commission | PubMed |
Source PubMed
References323
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 25670861 | MicroRNA-873 (miRNA-873) inhibits glioblastoma tumorigenesis and metastasis by suppressing the expression of IGF2BP1. | J Biol Chem | 2015 | https://conductscience.org/library/papers/25670861 | PubMed |
| 2 | 33054406 | M6A Demethylase FTO Plays a Tumor Suppressor Role in Thyroid Cancer. | DNA Cell Biol | 2020 | https://conductscience.org/library/papers/33054406 | PubMed |
| 3 | 32956555 | Downregulation of m6 A reader YTHDC2 promotes tumor progression and predicts poor prognosis in non-small cell lung cancer. | Thorac Cancer | 2020 | https://conductscience.org/library/papers/32956555 | PubMed |
| 4 | 33533172 | Kinase GSK3β functions as a suppressor in colorectal carcinoma through the FTO-mediated MZF1/c-Myc axis. | J Cell Mol Med | 2021 | https://conductscience.org/library/papers/33533172 | PubMed |
| 5 | 28809393 | Ythdc2 is an N6-methyladenosine binding protein that regulates mammalian spermatogenesis. | Cell Res | 2017 | https://conductscience.org/library/papers/28809393 | PubMed |
| 6 | 32805088 | The FTO/miR-181b-3p/ARL5B signaling pathway regulates cell migration and invasion in breast cancer. | Cancer Commun (Lond) | 2020 | https://conductscience.org/library/papers/32805088 | PubMed |
| 7 | 32449584 | m6 A demethylase ALKBH5 promotes proliferation of esophageal squamous cell carcinoma associated with poor prognosis. | Genes Cells | 2020 | https://conductscience.org/library/papers/32449584 | PubMed |
| 8 | 34301762 | M6A Demethylase ALKBH5 Regulates PD-L1 Expression and Tumor Immunoenvironment in Intrahepatic Cholangiocarcinoma. | Cancer Res | 2021 | https://conductscience.org/library/papers/34301762 | PubMed |
| 9 | 29399123 | MicroRNA-124-3p inhibits cell growth and metastasis in cervical cancer by targeting IGF2BP1. | Exp Ther Med | 2018 | https://conductscience.org/library/papers/29399123 | PubMed |
| 10 | 26121403 | Single-nucleotide-resolution mapping of m6A and m6Am throughout the transcriptome. | Nat Methods | 2015 | https://conductscience.org/library/papers/26121403 | PubMed |
| 11 | 32323801 | METTL14 promotes the migration and invasion of breast cancer cells by modulating N6‑methyladenosine and hsa‑miR‑146a‑5p expression. | Oncol Rep | 2020 | https://conductscience.org/library/papers/32323801 | PubMed |
| 12 | 32854717 | Roles of METTL3 in cancer: mechanisms and therapeutic targeting. | J Hematol Oncol | 2020 | https://conductscience.org/library/papers/32854717 | PubMed |
| 13 | 34162562 | IGF2BP1/UHRF2 Axis Mediated by miR-98-5p to Promote the Proliferation of and Inhibit the Apoptosis of Esophageal Squamous Cell Carcinoma. | Ann Clin Lab Sci | 2021 | https://conductscience.org/library/papers/34162562 | PubMed |
| 14 | 33059689 | Connecting METTL3 and intratumoural CD33+ MDSCs in predicting clinical outcome in cervical cancer. | J Transl Med | 2020 | https://conductscience.org/library/papers/33059689 | PubMed |
| 15 | 31281898 | Single-base mapping of m6A by an antibody-independent method. | Sci Adv | 2019 | https://conductscience.org/library/papers/31281898 | PubMed |
| 16 | 33094561 | IGF2BP3 facilitates cell proliferation and tumorigenesis via modulation of JAK/STAT signalling pathway in human bladder cancer. | J Cell Mol Med | 2020 | https://conductscience.org/library/papers/33094561 | PubMed |
| 17 | 34496932 | ALKBH5-HOXA10 loop-mediated JAK2 m6A demethylation and cisplatin resistance in epithelial ovarian cancer. | J Exp Clin Cancer Res | 2021 | https://conductscience.org/library/papers/34496932 | PubMed |
| 18 | 33207095 | Endometrial Cancer. | N Engl J Med | 2020 | https://conductscience.org/library/papers/33207095 | PubMed |
| 19 | 33023892 | The RNA m6A Reader YTHDF2 Maintains Oncogene Expression and Is a Targetable Dependency in Glioblastoma Stem Cells. | Cancer Discov | 2021 | https://conductscience.org/library/papers/33023892 | PubMed |
| 20 | 34335955 | Silencing of METTL3 effectively hinders invasion and metastasis of prostate cancer cells. | Theranostics | 2021 | https://conductscience.org/library/papers/34335955 | PubMed |
Cited by156
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 213 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42840625 | The methylation pattern of osimertinib resistance: prospects for diagnosis and treatment of NSCLC. | Front Oncol | 2026 | https://conductscience.org/library/papers/42840625 | PubMed |
| 42665759 | Mechanistic Study of m5C Modification in Stem Cell Differentiation and Disease Regulation. | Stem Cell Rev Rep | 2026 | https://conductscience.org/library/papers/42665759 | PubMed |
| 42435175 | Influence of RNA Modifications on Cancer Metabolism: Interplay with Hypoxia and Therapeutic Implications. | Adv Exp Med Biol | 2026 | https://conductscience.org/library/papers/42435175 | PubMed |
| 42399631 | GDPPH1 induces cell cycle arrest by downregulation of CDK4/Cyclin D1 via the m6A-METTL14-YTHDF2 axis, attenuating glioblastoma progression. | Cell Death Dis | 2026 | https://conductscience.org/library/papers/42399631 | PubMed |
| 42328436 | RNA variation as the driver of genomic efficiency and phenotypic complexity. | Int J Biol Sci | 2026 | https://conductscience.org/library/papers/42328436 | PubMed |
| 42240709 | FTO Deficiency Inhibits Vascular Endothelial Cell Apoptosis and Improved Mitophagy in Obesity-Related Hypertension by Enhancing NDRG1 m6A Methylation. | Biochem Genet | 2026 | https://conductscience.org/library/papers/42240709 | PubMed |
| 42223535 | The crucial role of m6A methylation modification in nasopharyngeal carcinoma. | Discov Oncol | 2026 | https://conductscience.org/library/papers/42223535 | PubMed |
| 42218253 | ALKBH5 aggravates scarring after glaucoma surgery via m6A-YTHDF2-mediated NLRP3 mRNA stabilization. | Cell Death Differ | 2026 | https://conductscience.org/library/papers/42218253 | PubMed |
| 42144760 | PDE4D Mediates the Cardiac Ischemia Reperfusion Injury and Is m6A Modified by METTL14. | Korean Circ J | 2026 | https://conductscience.org/library/papers/42144760 | PubMed |
| 42113318 | RBM15/IGF2BP2-PTPRH m6A regulatory axis in non-small cell lung cancer. | Cell Oncol (Dordr) | 2026 | https://conductscience.org/library/papers/42113318 | PubMed |
| 42102015 | Pyroptosis Regulated by N6-Methyladenosine Modification: Implications for Pyroptosis-Related Disease Therapy. | J Innate Immun | 2026 | https://conductscience.org/library/papers/42102015 | PubMed |
| 42093977 | RNA methylation in urological cancers: regulatory logic, biological functions, and clinical relevance. | Front Immunol | 2026 | https://conductscience.org/library/papers/42093977 | PubMed |
| 42031695 | Uncovering a role for METTL13 in malignant transformation of human hematopoietic stem cells and in the progression of pediatric leukemia. | Cell Death Dis | 2026 | https://conductscience.org/library/papers/42031695 | PubMed |
| 41949706 | Targeting the RNA-binding motif protein 15 suppresses prostate cancer progression and hormone therapy resistance by promoting androgen receptor degradation. | Mol Biomed | 2026 | https://conductscience.org/library/papers/41949706 | PubMed |
| 41878447 | Integrative single-cell, spatial, and bulk transcriptomics reveal an FMR1-FTO axis linked to the immune-excluded phenotype in gastric cancer. | Front Immunol | 2026 | https://conductscience.org/library/papers/41878447 | PubMed |
| 41852637 | The Future of Epigenetics: Emerging Technologies and Clinical Applications. | ACS Pharmacol Transl Sci | 2026 | https://conductscience.org/library/papers/41852637 | PubMed |
| 41827726 | m6A RNA Methylation Promotes the Melanoma Metastasis Mediated by Extracellular Vesicle miR-23a-5p. | Cancers (Basel) | 2026 | https://conductscience.org/library/papers/41827726 | PubMed |
| 41800248 | Interaction between m6A and YAP1 mechanotransduction pathways is essential for mechanical memory and matrix remodeling in pancreatic cancer. | Int J Biol Sci | 2026 | https://conductscience.org/library/papers/41800248 | PubMed |
| 41776401 | ALKBH5 promotes ovarian cancer progression by activating Notch2 signaling. | Biol Proced Online | 2026 | https://conductscience.org/library/papers/41776401 | PubMed |
| 41764519 | SERPINA4 facilitates colorectal cancer progression through m⁶A-dependent stabilization. | J Transl Med | 2026 | https://conductscience.org/library/papers/41764519 | PubMed |
Genes165
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/35945641
GET https://conductscience.org/api/papers/v1/35945641/references?page=2